Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian L Johnston

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
American Journal of Respiratory and Critical Care Medicine|October 3, 2019
IFN Therapy in Airway Disease: Is Prophylaxis a New Approach in Exacerbation Prevention?Sebastian L Johnston
Allergy|May 3, 2020
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?Sebastian L Johnston
American Journal of Respiratory and Critical Care Medicine|February 18, 2021
A, B, and C Rhinoviruses: New Knowledge from an Impressive Consortium. A Step Forward for Rhinovirus Vaccine Efforts or a Step Back?Sebastian L Johnston
The Journal of Allergy and Clinical Immunology|June 6, 2006
Macrolide antibiotics and asthma treatmentSebastian L Johnston
American Journal of Respiratory and Critical Care Medicine|July 2, 2016
IFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma?Sebastian L Johnston
Proceedings of the American Thoracic Society|August 23, 2005
Overview of virus-induced airway diseaseSebastian L Johnston
Virus Research|March 12, 2002
Anti-influenza therapiesSebastian L Johnston
American Journal of Respiratory and Critical Care Medicine|November 11, 2003
Experimental models of rhinovirus-induced exacerbations of asthma: where to now?Sebastian L Johnston
Proceedings of the American Thoracic Society|July 4, 2007
Innate immunity in the pathogenesis of virus-induced asthma exacerbationsSebastian L Johnston
Pulmonary Pharmacology & Therapeutics|May 30, 2009
Cough and viruses in airways disease: mechanismsJoseph Footitt, Sebastian L Johnston
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
American Journal of Respiratory and Critical Care Medicine|October 3, 2019
IFN Therapy in Airway Disease: Is Prophylaxis a New Approach in Exacerbation Prevention?Sebastian L Johnston
Allergy|May 3, 2020
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?Sebastian L Johnston
American Journal of Respiratory and Critical Care Medicine|February 18, 2021
A, B, and C Rhinoviruses: New Knowledge from an Impressive Consortium. A Step Forward for Rhinovirus Vaccine Efforts or a Step Back?Sebastian L Johnston
The Journal of Allergy and Clinical Immunology|June 6, 2006
Macrolide antibiotics and asthma treatmentSebastian L Johnston
American Journal of Respiratory and Critical Care Medicine|July 2, 2016
IFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma?Sebastian L Johnston
Proceedings of the American Thoracic Society|August 23, 2005
Overview of virus-induced airway diseaseSebastian L Johnston
Virus Research|March 12, 2002
Anti-influenza therapiesSebastian L Johnston
American Journal of Respiratory and Critical Care Medicine|November 11, 2003
Experimental models of rhinovirus-induced exacerbations of asthma: where to now?Sebastian L Johnston
Proceedings of the American Thoracic Society|July 4, 2007
Innate immunity in the pathogenesis of virus-induced asthma exacerbationsSebastian L Johnston
Pulmonary Pharmacology & Therapeutics|May 30, 2009
Cough and viruses in airways disease: mechanismsJoseph Footitt, Sebastian L Johnston
Pageof 30